More than 6 million Americans currently live with Alzheimer's disease, a number predicted to rise as our population ages.

New global study shows childhood vaccine coverage stalled by COVID-19, with urgent need to boost immunisation by 2030 to meet WHO targets.

The BCG vaccine was first used against TB in the 1920's and then started to be used as the first cancer immunotherapy around ...

BCG vaccine—named for its developers—contains inactivated mycobacteria that infect cattle and remains the only vaccination strategy against the infection in humans.

The treatment consists of instilling the BCG vaccine directly into the bladder. When the treatment works, the 15-year survival rate for patients with so-called “non-muscle-invasive” (early ...

The Therapeutic BCG Vaccine Market offers growth opportunities through expanding applications beyond TB prevention, including bladder cancer and autoimmune diseases. Advances in biotechnology ...

Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long COVID. A phase 3 clinical trial initiated in early ...

Initial QFT test conversion after day 71 of follow-up occurred in 135 participants (15.5%) in the BCG-vaccine group and 125 participants (14.7%) in the placebo group.

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes.

BCG Vaccine Market Size and Forecast. According to analysts at Vantage Market Research, the global BCG (Bacillus Calmette-Guerin) Vaccine Market is projected to witness significant growth in the ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...